Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan N Basile

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|December 22, 2009
Largest meta-analysis to date suggests that patients at risk for cardiovascular disease events derive benefit from antihypertensive therapy regardless of baseline blood pressure and to reduce vascular events, lowering blood pressure is more important than choice of antihypertensive drug classMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|October 11, 2008
Analysis of recent papers in hypertensionMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|April 17, 2009
Analysis of recent papers in hypertensionMichael J Bloch, Jan N Basile
Postgraduate Medicine|August 12, 2009
Beta-blockers for preventing sudden cardiac deathThomas D Giles, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|August 3, 2011
Spironolactone is more effective than eplerenone at lowering blood pressure in patients with primary aldosteronismMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|May 6, 2008
Analysis of recent papers in hypertension: a simple office-based tool to predict the development of hypertensionMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2012
Exposure to air pollution increases the incidence of hypertension and diabetes in black women living in Los AngelesJan N Basile, Michael J Bloch
Journal of the American Society of Hypertension : JASH|November 25, 2014
Recent clinical trialsAlan H Gradman, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|October 30, 2010
Combination angiotensin receptor blocker-neutral endopeptidase inhibitor provides additive blood pressure reduction over angiotensin receptor blocker aloneMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|November 5, 2011
New British guidelines mandate ambulatory blood pressure monitoring to diagnose hypertension in all patients: not ready for prime time in the United StatesMichael J Bloch, Jan N Basile
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Journal of Clinical Hypertension (Greenwich, Conn.)|December 22, 2009
Largest meta-analysis to date suggests that patients at risk for cardiovascular disease events derive benefit from antihypertensive therapy regardless of baseline blood pressure and to reduce vascular events, lowering blood pressure is more important than choice of antihypertensive drug classMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|October 11, 2008
Analysis of recent papers in hypertensionMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|April 17, 2009
Analysis of recent papers in hypertensionMichael J Bloch, Jan N Basile
Postgraduate Medicine|August 12, 2009
Beta-blockers for preventing sudden cardiac deathThomas D Giles, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|August 3, 2011
Spironolactone is more effective than eplerenone at lowering blood pressure in patients with primary aldosteronismMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|May 6, 2008
Analysis of recent papers in hypertension: a simple office-based tool to predict the development of hypertensionMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2012
Exposure to air pollution increases the incidence of hypertension and diabetes in black women living in Los AngelesJan N Basile, Michael J Bloch
Journal of the American Society of Hypertension : JASH|November 25, 2014
Recent clinical trialsAlan H Gradman, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|October 30, 2010
Combination angiotensin receptor blocker-neutral endopeptidase inhibitor provides additive blood pressure reduction over angiotensin receptor blocker aloneMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|November 5, 2011
New British guidelines mandate ambulatory blood pressure monitoring to diagnose hypertension in all patients: not ready for prime time in the United StatesMichael J Bloch, Jan N Basile
Pageof 11